Elegen

Developer of microfluidics technology designed to disrupt synthetic biology. The company leverages technology for the engineering of entire genomes and the rapid development of DNA synthesizers aimed ...

Healthcare

Menlo Park, CA, United States

Founded 2017

96 employees

Website

Valuation

$100M

Market implied

Share Price

N/A

Total Raised

$56.6M

Last Round

N/A

Investors

+17 other investors

View all 17 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Elegen's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required